Atlanta Business Chronicle by Urvaksh Karkaria, Staff Writer
A Suwanee based biotech has raised $4.3 million, according to a Securities & Exchange Commission filing.
Halscion Inc. is developing a device for the reduction in the appearance of scars resulting from acute surgical wounds.
The company has raised $4.5 million in Series A financing. Investors in the company include Accuitive Medical Ventures, Versant Ventures and SV Life Sciences.
Halscion, founded in 2008, is located in the Innovation Factory, a privately funded health-care incubator with a portfolio of eight companies.